Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : VNDA save search
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
Published: 2021-02-10 (Crawled : 21:11) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: 5.19%
H: 19.8%
C: 15.18%
financial results results
Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference
Published: 2023-09-06 (Crawled : 22:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: -0.91%
H: 5.75%
C: 5.06%
conference pharmaceuticals global
UroGen Announces New Data from the OLYMPUS Trial that Shows Median Durability of Response of 28.9 Months for JELMYTO®, the Only Non-Surgical, Chemoablative Treatment for Adults with Low-Grade Upper Tra...
Published: 2022-12-02 (Crawled : 13:00) - biospace.com/
WDH | $1.23 0.0% 240K
|
Finance and Insurance
|
| O: -3.09%
H: 6.37%
C: 2.55%
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: -0.55%
H: 0.64%
C: 0.09%
URGN | $14.32 0.56% 0.56% 320K
|
Health Technology
|
| O: -1.49%
H: 3.84%
C: -2.44%
SNDX | $20.44 -1.45% -1.47% 1.2M
|
Health Technology
|
| O: -0.16%
H: 1.12%
C: 0.32%
GTHX | $4.16 -2.8% -2.88% 690K
|
Health Technology
|
| O: -2.22%
H: 9.27%
C: 7.69%
ACET | $2.02 -11.01% -12.38% 930K
|
Health Technology
|
| O: -1.13%
H: 5.01%
C: 4.84%
jelmyto treatment trial response
Vanda Pharmaceuticals to Announce Third Quarter 2023 Financial Results on November 8, 2023
Published: 2023-11-01 (Crawled : 21:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: -0.23%
H: 2.98%
C: 2.52%
pharmaceuticals financial results
Vanda Pharmaceuticals Appoints Dr. Tage Honoré to its Board of Directors
Published: 2023-03-17 (Crawled : 12:20) - biospace.com/
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: 0.0%
H: 3.53%
C: 2.35%
pharmaceuticals
Fanapt® Shown to be Effective in Bipolar I Disorder in Phase III Clinical Study
Published: 2022-12-19 (Crawled : 12:20) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: 0.0%
H: 3.97%
C: 2.27%
fanapt study
Vanda Pharmaceuticals Announces Participation at November 2021 Investor Conferences
Published: 2021-11-10 (Crawled : 00:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: -1.39%
H: 2.64%
C: 1.97%
conference
Vanda Pharmaceuticals Announces Presentations at SLEEP 2023
Published: 2023-06-02 (Crawled : 02:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: 0.85%
H: 2.18%
C: 1.85%
pharmaceuticals
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S
Published: 2023-06-02 (Crawled : 02:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: 0.85%
H: 2.18%
C: 1.85%
vca-894 drug candidate granted treatment pharmaceuticals designation
Vanda Pharmaceuticals Closes Enrollment In The ODYSSEY Study Comparing Tradipitant And Placebo In Hospitalized COVID-19 Pneumonia Patients
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: -1.6%
H: 1.86%
C: 1.68%
covid enroll
Vanda Pharmaceuticals Reports Second Quarter 2021 Financial Results
Published: 2021-07-28 (Crawled : 21:00) - biospace.com/
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: -0.21%
H: 1.92%
C: 1.4%
financial results results
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VPO-227, a Novel Candidate for the Treatment of Cholera
Published: 2022-10-21 (Crawled : 23:00) - biospace.com/
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: 1.89%
H: 1.95%
C: 1.27%
vpo-227 treatment pharmaceuticals designation drug candidate granted
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results on February 8, 2023
Published: 2023-02-01 (Crawled : 00:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: 1.04%
H: 2.84%
C: 1.03%
pharmaceuticals year financial results
Vanda Pharmaceuticals Intends to Petition the U.S. Supreme Court in its HETLIOZ® ANDA Litigation
Published: 2023-10-20 (Crawled : 11:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: -0.23%
H: 2.79%
C: 0.93%
hetlioz pharmaceuticals
Vanda Pharmaceuticals Announces Participation in the Jefferies 2023 Global Healthcare Conference
Published: 2023-06-05 (Crawled : 11:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: -0.17%
H: 1.16%
C: 0.83%
conference pharmaceuticals global
Vanda Pharmaceuticals and OliPass Announce Strategic Partnership to Develop Antisense Oligonucleotide Therapeutics
Published: 2022-09-29 (Crawled : 21:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: 0.31%
H: 3.06%
C: 0.82%
partnership pharmaceuticals therapeutics
Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference
Published: 2023-01-06 (Crawled : 15:00) - biospace.com/
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: 0.82%
H: 1.74%
C: 0.82%
pharmaceuticals conference
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
Published: 2022-02-17 (Crawled : 00:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: -1.26%
H: 1.73%
C: 0.75%
als financial results results
Vanda Pharmaceuticals to Announce Second Quarter 2021 Financial Results on July 28, 2021
Published: 2021-07-21 (Crawled : 21:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: 0.36%
H: 1.5%
C: 0.73%
financial results results
Vanda Pharmaceuticals Announces Presentations at DDW 2023
Published: 2023-05-04 (Crawled : 22:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: 0.44%
H: 1.45%
C: 0.72%
pharmaceuticals
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.